Dorval Allison insider trades
Dorval Allison has filed 22 Form 4s with the SEC that we hold, for VERV (Chief Financial Officer), Puma Biotechnology, INC. (PBYI) (Director) and Jade Biosciences, Inc. (AVTE) (Director). Across all of them we count 0 purchases worth $0 and 8 sales worth $230.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($83.6K). The largest single trade was a sale of 11,610 shares of Puma Biotechnology, INC. worth $83.6K, dated 2026-06-12. The first filing on our record is dated 2021-07-16 and the latest 2026-06-15.
VERV
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-29 | S, sale reported on Form 4 | 554 | $12.2K | 2022-12-01 |
| 2023-11-29 | S, sale reported on Form 4 | 554 | $6.3K | 2023-12-01 |
| 2024-12-02 | S, sale reported on Form 4 | 555 | $3.1K | 2024-12-03 |
| 2025-04-02 | S, sale reported on Form 4 | 3,350 | $13.9K | 2025-04-03 |
Puma Biotechnology, INC. (PBYI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-13 | S, sale reported on Form 4 | 10,000 | $34.5K | 2023-06-15 |
| 2024-06-13 | S, sale reported on Form 4 | 11,000 | $37.1K | 2024-06-17 |
| 2025-06-13 | S, sale reported on Form 4 | 11,610 | $39.5K | 2025-06-17 |
| 2026-06-12 | S, sale reported on Form 4 | 11,610 | $83.6K | 2026-06-15 |
Jade Biosciences, Inc. (AVTE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1625110) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms